Latest Breaking News On - Hannah deresiewicz - Page 5 : comparemela.com

NewAmsterdam Pharma Announces Pricing of $175 3 Million Public Offering of Ordinary Shares and

NAARDEN, the Netherlands and MIAMI, Feb. 13, 2024 (GLOBE NEWSWIRE) NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines

Noord hollandUnited statesNew yorkHannah deresiewiczPiper sandlerNeither the companyLeerink partnersPiper sandler coProspectus departmentSyndicate departmentExchange commissionNewamsterdam pharma companynv nasdaqCapital marketsEquity syndicate prospectus departmentOrdinary sharesFunded warrants

NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants

NAARDEN, The Netherlands and MIAMI, Feb. 13, 2024 (GLOBE NEWSWIRE) NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Com.

United statesNew yorkNoord hollandHannah deresiewiczPiper sandlerEquity syndicate prospectus departmentProspectus departmentSyndicate departmentPiper sandler coNewamsterdam pharma companynv nasdaqNeither the companyExchange commissionCapital marketsLeerink partnersOrdinary sharesFunded warrants

NewAmsterdam Pharma Announces Pricing of $175 3 Million

NAARDEN, the Netherlands and MIAMI, Feb. 13, 2024 (GLOBE NEWSWIRE) NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a.

United statesNoord hollandNew yorkPiper sandlerHannah deresiewiczEquity syndicate prospectus departmentLeerink partnersNewamsterdam pharma companynv nasdaqExchange commissionPiper sandler coProspectus departmentSyndicate departmentNeither the companyCapital marketsOrdinary sharesFunded warrants

Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

CAMBRIDGE, Mass., Feb. 01, 2024 Prime Medicine, Inc. , a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that.

New yorkUnited statesUnited kingdomKeith gottesdienerDan budwickHannah deresiewiczStern investor relations incMedicine incChief executive officerPrime medicineGuggenheim healthcare talksAnnual biotechnology conferencePrime editingPrime editorsInvestor relations

NewAmsterdam Pharma to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

NewAmsterdam Pharma to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNoord hollandMatthew philippeIan somaiyaJen gordonMichael davidsonHannah deresiewiczNewamsterdam pharmaCompany contactNewamsterdam pharma companynv nasdaqGuggenheim healthcare talksAnnual biotechnology conferenceAmsterdam pharmaInvestor relations